Production (Stage)
Tenax Therapeutics, Inc.
TENX
$6.15
$0.081.32%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -24.21M | -17.60M | -14.56M | -12.57M | -10.10M |
| Total Depreciation and Amortization | -- | -- | 5.10K | 6.10K | 7.10K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 5.16M | 1.15M | 219.10K | 243.50K | 268.30K |
| Change in Net Operating Assets | 2.44M | 1.64M | 1.88M | 869.80K | 482.80K |
| Cash from Operations | -16.61M | -14.81M | -12.46M | -11.45M | -9.35M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | 200.00 | 200.00 | 1.80K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | 200.00 | 200.00 | 1.80K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -413.30K | -501.30K | -675.40K | -567.90K | -601.70K |
| Issuance of Common Stock | 92.30M | 91.95M | 91.95M | 1.00K | 69.30K |
| Repurchase of Common Stock | -100.24M | -100.24M | -14.19M | -14.48M | -14.48M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 123.86M | 108.65M | 22.54M | 22.48M | 22.48M |
| Cash from Financing | 115.51M | 99.87M | 99.63M | 7.44M | 7.48M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 98.90M | 85.06M | 87.17M | -4.01M | -1.87M |